Virbac stock reports 7.4 percent first half revenue growth

Published on 09/25/2026 at 12:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Virbac stock has H1 revenue of EUR 768 million for the period ended June 30, 2026. Adjusted EBIT reached EUR 144.2 million, while the 2026 growth target stayed at 5.5 percent to 7.5 percent.

Modernes Pharmawerk für Tiergesundheit in sonniger südfranzösischer Landschaft — Fotorealistische Aufnahme zeigt Veterinärpharma-Anlage von Virbac S.A., passend zu ISIN FR0000031577, moderner Standort Südfrankreich, Illustration mit AI erstellt.

Virbac stock (ISIN FR0000031577) was trading at EUR 303 on Euronext Paris on September 25, 2026 at 11:44 a.m. CEST, up 0.33 percent from EUR 302. The animal-health company delivered EUR 768 million of revenue in the first half of 2026, giving the stock a results-based valuation story rather than a purely technical one.

Revenue growth reaches 7.4 percent

According to Virbac in its release dated September 17, 2026, first-half revenue rose 7.4 percent at constant exchange rates and scope, while growth at actual exchange rates was 4.0 percent. Companion-animal revenue increased 10.0 percent and farm-animal revenue rose 6.7 percent.

The profit mix was also stronger. Adjusted EBIT reached EUR 144.2 million in H1 2026 versus EUR 135.0 million in H1 2025, an increase of 6.8 percent, while the adjusted EBIT margin advanced to 18.8 percent from 18.3 percent.

Bernstein lifts its price target

On September 21, 2026, Bernstein upgraded Virbac from Market Perform to Outperform and raised its price target from EUR 419 to EUR 426, according to Investing.com. The new target puts the price target 40.6 percent above the EUR 303 reference price.

Virbac's full-year 2026 revenue growth guidance remains 5.5 percent to 7.5 percent at constant exchange rates and scope, with management targeting the upper end. The adjusted recurring operating income margin target is 17 percent, below the 18.8 percent achieved in the first half because the business is typically more profitable in the first half.

Virbac stock sits 2.02 percent above its yearly low

Virbac stock was trading at EUR 303 on Euronext Paris on September 25, 2026 at 11:44 a.m. CEST, with 832 shares changing hands. Its 52-week range was EUR 297 to EUR 389.50, placing the quote 2.02 percent above the low, while market capitalization stood at EUR 2,538,480,672.